Evidence map›Paper›PMID 33471808›Full record

ArticlePloS one2021

Validation of prognostic indices for short term mortality in an incident dialysis population of older adults >75.

Bjorg Thorsteinsdottir, LaTonya J Hickson, Rachel Giblon, Atieh Pajouhi, Natalie Connell, Megan Branda, Amrit K Vasdev, Rozalina G McCoy, Ladan Zand, Navdeep Tangri and 1 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bjorg ThorsteinsdottirDivision of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.ORCID 0000-0002-4397-728X
LaTonya J HicksonKern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, United States of America.
Rachel GiblonKnowledge Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, United States of America.
Atieh PajouhiDivision of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Natalie ConnellBiomedical Ethics Program, Mayo Clinic, Rochester, Minnesota, United States of America.
Megan BrandaKnowledge Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, United States of America.
Amrit K VasdevDivision of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Rozalina G McCoyDivision of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Ladan ZandDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Navdeep TangriDepartment of Medicine, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Canada.
Nilay D ShahKnowledge Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, United States of America.

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Yale-Mayo FDA Center for Excellence in Regulatory Science and InnovationU01FD005938 · FDA · YALE UNIVERSITY · PI Joseph Solomon Ross · 2016 to 2026
$25.4M
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)R01HL131535 · NHLBI · MAYO CLINIC ROCHESTER · PI MONTORI, VICTOR MANUEL · 2016 to 2020
$3.2M
Gastrointestinal Safety of Antithrombotic Drug RegimensR01HS025402 · AHRQ · MAYO CLINIC ARIZONA · PI ABRAHAM, NEENA S · 2017 to 2020
$1.6M
Medical reversals: De-implementing ineffective and unsafe treatmentsR01HS025164 · AHRQ · UNIVERSITY OF MINNESOTA · PI KARACA-MANDIC, PINAR · 2017 to 2020
$1.4M
Mesenchymal stem cell senescence in diabetic nephropathy (K23 COVID Admin Supplement)K23DK109134 · NIDDK · MAYO CLINIC ROCHESTER · PI HICKSON, LATONYA J · 2016 to 2021
$1.0M
Evidence Based Encounter Decision Aid for Elderly Patients to Promote Shared Decision Making on Treatment Choice in End Stage Renal DiseaseK23AG051679 · NIA · MAYO CLINIC ROCHESTER · PI THORSTEINSDOTTIR, BJOERG · 2016 to 2020
$908k
Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with DiabetesK23DK114497 · NIDDK · MAYO CLINIC ROCHESTER · PI MCCOY, ROZALINA GRUBINA · 2017 to 2021
$846k
Diffusion of Clinical Evidence into Practice: Physician Networks, Delivery Organizations, and MarketsR56HL130496 · NHLBI · UNIVERSITY OF MINNESOTA · PI KARACA-MANDIC, PINAR · 2016 to 2016
$634k
The ICAN Discussion Aid to Optimize Treatment for People Living with Multiple Chronic ConditionsR03HS025517 · AHRQ · MAYO CLINIC ROCHESTER · PI SHAH, NILAY D · 2017 to 2018
$100k
AHRQ HHS R01 HS025164AHRQ HHS R01 HS025402AHRQ HHS R03 HS025517FDA HHS U01 FD005938NCATS NIH HHS UL1 TR000135NHLBI NIH HHS R01 HL131535NHLBI NIH HHS R56 HL130496NIA NIH HHS K23 AG051679NIDDK NIH HHS K23 DK109134NIDDK NIH HHS K23 DK114497
6 · The paper itself

Abstract

RATIONAL AND

objectivePrognosis provides critical knowledge for shared decision making between patients and clinicians. While several prognostic indices for mortality in dialysis patients have been developed, their performance among elderly patients initiating dialysis is unknown, despite great need for reliable prognostication in that context. To assess the performance of 6 previously validated prognostic indices to predict 3 and/or 6 months mortality in a cohort of elderly incident dialysis patients. STUDY

designValidation study of prognostic indices using retrospective cohort data. Indices were compared using the concordance ("c")-statistic, i.e. area under the receiver operating characteristic curve (ROC). Calibration, sensitivity, specificity, positive and negative predictive values were also calculated. SETTING &

participantsIncident elderly (age ≥75 years; n = 349) dialysis patients at a tertiary referral center. ESTABLISHED PREDICTORS: Variables for six validated prognostic indices for short term (3 and 6 month) mortality prediction (Foley, NCI, REIN, updated REIN, Thamer, and Wick) were extracted from the electronic medical record. The indices were individually applied as per each index specifications to predict 3- and/or 6-month mortality.

resultsIn our cohort of 349 patients, mean age was 81.5±4.4 years, 66% were male, and median survival was 351 days. The c-statistic for the risk prediction indices ranged from 0.57 to 0.73. Wick ROC 0.73 (0.68, 0.78) and Foley 0.67 (0.61, 0.73) indices performed best. The Foley index was weakly calibrated with poor overall model fit (p <0.01) and overestimated mortality risk, while the Wick index was relatively well-calibrated but underestimated mortality risk. LIMITATIONS: Small sample size, use of secondary data, need for imputation, homogeneous population.

conclusionMost predictive indices for mortality performed moderately in our incident dialysis population. The Wick and Foley indices were the best performing, but had issues with under and over calibration. More accurate indices for predicting survival in older patients with kidney failure are needed.

Indexed as

AgedAged, 80 and overArea Under CurveComorbidityFemaleHumansKidney Failure, ChronicMalePredictive Value of TestsPrognosisRenal DialysisRetrospective StudiesRisk AssessmentROC CurveSurvival RateTertiary Care Centers

Identifiers

PMID33471808
PMCPMC7816982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.